Produktname:Triphenylmethyl chloride
- CAS:76-83-5
- Molekulare Formel:C19H15Cl
- Reinheit:95%+
- Katalognummer:CM000181
- Molekulargewicht:278.78
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:76-83-5
- Molekulare Formel:C19H15Cl
- Schmelzpunkt:-
- SMILES-Code:ClC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3
- Dichte:
- Katalognummer:CM000181
- Molekulargewicht:278.78
- Siedepunkt:
- Mdl-Nr.:MFCD00000813
- Lagerung:
Column Infos
- Zegocractin
- CalciMedica announces positive topline data from phase 2b CARPO trial of Auxora™ in Acute Pancreatitis (AP). The trial met primary objective with statistically significant dose response. Calcium release–activated calcium (CRAC) channels are involved in activating T cells, and responsible for regulating calcium-dependent inflammatory pathways or tissue cell injury pathways. AP is a potentially life-threatening inflammatory disease of the pancreas featured by aberrant signaling of calcium.
CalciMedica’s Auxora is a potent and selective intravenous formulated CRAC channel inhibitor containing the active ingredient Zegocractin. It is being developed for the treatment of acute inflammatory and immunologic illnesses, including severe AP, AIPT, AKI, and severe acute respiratory diseases including AHRF, and ARDS.